{domain:"www.qualitydigest.com",server:"169.47.211.87"} Skip to main content

User account menu
Main navigation
  • Topics
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Videos/Webinars
    • All videos
    • Product Demos
    • Webinars
  • Advertise
    • Advertise
    • Submit B2B Press Release
    • Write for us
  • Metrology Hub
  • Training
  • Subscribe
  • Log in
Mobile Menu
  • Home
  • Topics
    • 3D Metrology-CMSC
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Login / Subscribe
  • More...
    • All Features
    • All News
    • All Videos
    • Contact
    • Training

Nationwide Recall of Prefilled Heparin and Normal Saline Flushes

AM2 PAT Inc.
Tue, 02/26/2008 - 22:00
  • Comment
  • RSS

Social Sharing block

  • Print
Body

(AM2 PAT Inc.: Angier, North Carolina) -- A nationwide recall of Heparin and Saline prefilled flushes manufactured by AM2 PAT was issued by AM2 PAT. These products are distributed under two brand names, Sierra Pre-Filled Inc. and B. Braun. These products are sold in 3-ml and 5-ml sizes for Heparin and 3-ml, 5-ml, and 10-ml sizes for Normal Saline. Both products are sold as prefilled syringes. The firm voluntarily recalled these products after confirming bacterial contamination in some end-user samples.

It appears from an ongoing Food and Drug Administration inspection of AM2 PAT Inc.’s facility that the firm isn’t in compliance with the quality system regulation and failed to have adequate controls to ensure necessary sterility of its prefilled syringes.

One lot under recall of this product,1003-02, Lot 070926H, Heparin IV flush syringes has been found to be contaminated with Serratia marcescens, which has resulted in patient infections. The Center for Disease Control has confirmed growth of Serratia marcescens from several unopened syringes of this product.

 …

Want to continue?
Log in or create a FREE account.
Enter your username or email address
Enter the password that accompanies your username.
By logging in you agree to receive communication from Quality Digest. Privacy Policy.
Create a FREE account
Forgot My Password

Add new comment

Image CAPTCHA
Enter the characters shown in the image.
Please login to comment.
      

© 2025 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.

footer
  • Home
  • Print QD: 1995-2008
  • Print QD: 2008-2009
  • Videos
  • Privacy Policy
  • Write for us
footer second menu
  • Subscribe to Quality Digest
  • About Us
  • Contact Us